Glucotrack (GCTK) Research & Development (2010 - 2025)
Glucotrack (GCTK) reported Research & Development of $1.6 million for Q4 2025, down 4.24% year-on-year from $1.7 million in Q4 2024, and down 48.59% quarter-over-quarter from $3.2 million in Q3 2025.
Glucotrack (GCTK) has 15 years of Research & Development data on file, last reported at $1.6 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development fell 4.24% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $9.8 million (up 3.31% YoY), and the FY2025 full-year result was $9.8 million, up 3.31% from the prior year.
- Research & Development for Q4 2025 stood at $1.6 million, down from $3.2 million in the prior quarter.
- Across five years, Research & Development topped out at $3.6 million in Q2 2024 and bottomed at $309000.0 in Q1 2021.
- A 5-year average of $1.4 million and a median of $1.2 million in 2021 frame the typical range for Research & Development.
- Across the five-year window, Research & Development retreated 25.18% in 2021 and soared 472.41% in 2024, its largest moves.
- Tracing GCTK's Research & Development over 5 years: stood at $733000.0 in 2021, then dropped by 17.6% to $604000.0 in 2022, then soared by 188.41% to $1.7 million in 2023, then retreated by 2.47% to $1.7 million in 2024, then retreated by 4.24% to $1.6 million in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $1.6 million, $3.2 million, and $3.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 94.27 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 15.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 189.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 44.30 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 98.66 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 139.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 642,000.00 |
| Dec 31, 2022 | 604,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 733,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | 309,000.00 |
| Dec 31, 2020 | 264,000.00 |
| Sep 30, 2020 | 476,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 413,000.00 |
| Dec 31, 2019 | 402,384.00 |
| Sep 30, 2019 | 377,377.00 |
| Jun 30, 2019 | 401,122.00 |
| Mar 31, 2019 | 425,117.00 |
| Dec 31, 2018 | 1.21 Mn |
| Sep 30, 2018 | 534,129.00 |
| Jun 30, 2018 | 691,894.00 |
| Mar 31, 2018 | 592,697.00 |
| Dec 31, 2017 | 1.37 Mn |
| Sep 30, 2017 | 635,478.00 |
| Jun 30, 2017 | 616,824.00 |
| Mar 31, 2017 | 581,539.00 |
| Dec 31, 2016 | 654,984.00 |
| Sep 30, 2016 | 695,437.00 |
| Jun 30, 2016 | 880,696.00 |
| Mar 31, 2016 | 579,495.00 |
| Dec 31, 2015 | 671,851.00 |
| Sep 30, 2015 | 560,189.00 |
| Jun 30, 2015 | 557,980.00 |
| Mar 31, 2015 | 478,325.00 |
| Dec 31, 2014 | 522,047.00 |
| Sep 30, 2014 | 421,704.00 |
| Jun 30, 2014 | 454,789.00 |
| Mar 31, 2014 | 451,084.00 |
| Dec 31, 2012 | 497,326.00 |
| Sep 30, 2012 | 469,836.00 |
| Jun 30, 2012 | 508,462.00 |
| Mar 31, 2012 | 445,066.00 |
| Dec 31, 2011 | 547,110.00 |
| Sep 30, 2011 | 461,077.00 |
| Jun 30, 2011 | 407,631.00 |
| Mar 31, 2011 | 373,483.00 |
| Dec 31, 2010 | 255,856.00 |